You can:
Name | Kappa-type opioid receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | OPRK1 |
Synonym | K-OR-1 KOPr OP2 KOP KOR-1 [ Show all ] |
Disease | Obesity Opiate dependence Inflammatory bowel disease Erythema Diarrhea-predominant IBS [ Show all ] |
Length | 380 |
Amino acid sequence | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV |
UniProt | P41145 |
Protein Data Bank | 6b73, 4djh |
GPCR-HGmod model | P41145 |
3D structure model | This structure is from PDB ID 6b73. |
BioLiP | BL0402244,BL0402246, BL0224693,BL0224694, BL0402243,BL0402245 |
Therapeutic Target Database | T60693 |
ChEMBL | CHEMBL237 |
IUPHAR | 318 |
DrugBank | BE0000632 |
Name | Naltrindole |
---|---|
Molecular formula | C26H26N2O3 |
IUPAC name | (1S,2S,13R,21R)-22-(cyclopropylmethyl)-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol |
Molecular weight | 414.505 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 3 |
XlogP | 3.3 |
Synonyms | D0M2EX NTI 4,8-Methanobenzofuro(2,3-a)pyrido(4,3-b)carbazole-1,8a(9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-, (4bS,8R,8aS,14bR)- CHEBI:81528 GTPL1641 [ Show all ] |
Inchi Key | WIYUZYBFCWCCQJ-IFKAHUTRSA-N |
Inchi ID | InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1 |
PubChem CID | 5497186 |
ChEMBL | CHEMBL567175 |
IUPHAR | 1641, 3829 |
BindingDB | 50370067 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Activity | 12.0 % | PMID18637671 | ChEMBL |
Activity | 32.0 - | PMID7515442 | ChEMBL |
EC50 | 4.95 Ke nM-1 | PMID12672258 | ChEMBL |
EC50 | 4.95 nM | PMID12825957 | ChEMBL |
IC50 ratio | 5.4 - | PMID1851846 | ChEMBL |
Ke | 4.95 nM | PMID15456250, PMID15588100, PMID24973818, PMID11784158 | ChEMBL |
Ke | 16.1 nM | PMID14711299, PMID16942033 | ChEMBL |
Ki | 2.9 nM | PMID19282177 | ChEMBL |
Ki | 4.4 nM | PMID12930147 | ChEMBL |
Ki | 10.0 nM | PMID24973818, PMID9686407 | BindingDB,IUPHAR |
Ki | 10.1 nM | PMID12672258, PMID15588100, PMID12825957, PMID11784158, PMID15456250, PMID24973818 | ChEMBL |
Ki | 14.7 nM | PMID26048798 | ChEMBL |
Ki | 15.0 nM | PMID26048798 | BindingDB |
Ki | 30.0 nM | PMID11597422 | ChEMBL |
Ki | 75.0 nM | PMID19595591 | ChEMBL |
Ratio | 5.4 - | PMID8126697 | ChEMBL |
Ratio | 150.0 - | PMID12565965 | ChEMBL |
Selectivity ratio | 354.0 - | PMID9207938 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417